Efficacy and Safety/Tolerability of Grass MATA MPL

NCT00414141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1028

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I Hypersensitivity

Interventions

BIOLOGICAL: Grass MATA MPL
BIOLOGICAL: Placebo

Sponsor

Allergy Therapeutics